Skip to Main Content

Paper Details

Discovery of SARS-CoV-2 antiviral drugs through large-scale compound repurposing.
Nature
557
2020
COVID-19, MDL-28170, ONO 5334, PIKfyve kinase, SARS-, SARS-CoV, SARS-CoV-2, VBY-825, Z LVG CHN2, apilimod, apilimod2-4, coronavirus disease 2019, cysteine, human, human pneumocyte-like cells, induced pluripotent stem cells, patients, primary human lung explant model, severe acute respiratory syndrome coronavirus
Author NameAffiliation
Laura RivaSanford Burnham Prebys Medical Discovery Institute
Xin YinSanford Burnham Prebys Medical Discovery Institute
Laura Martin-SanchoSanford Burnham Prebys Medical Discovery Institute
Lars PacheSanford Burnham Prebys Medical Discovery Institute
Paul D De JesusSanford Burnham Prebys Medical Discovery Institute
Max W ChangUniversity of California
Yuan PuSanford Burnham Prebys Medical Discovery Institute
Raveen RathnasingheIcahn School of Medicine at Mount Sinai
Raveen RathnasingheGlobal Health and Emerging Pathogens Institute, Icahn School of Medicine at Mount Sinai
Raveen RathnasingheIcahn School of Medicine at Mount Sinai
Michael SchotsaertIcahn School of Medicine at Mount Sinai
Michael SchotsaertGlobal Health and Emerging Pathogens Institute, Icahn School of Medicine at Mount Sinai
Lisa MiorinIcahn School of Medicine at Mount Sinai
Lisa MiorinGlobal Health and Emerging Pathogens Institute, Icahn School of Medicine at Mount Sinai
Marion DejosezHuffington Foundation Center for Cell-based Research in Parkinson's Disease, Black Family Stem Cell Institute, Icahn School of Medicine at Mount Sinai
Thomas P ZwakaHuffington Foundation Center for Cell-based Research in Parkinson's Disease, Black Family Stem Cell Institute, Icahn School of Medicine at Mount Sinai
Luis Martinez-SobridoTexas Biomedical Research Institute
Kris M WhiteIcahn School of Medicine at Mount Sinai
Kris M WhiteGlobal Health and Emerging Pathogens Institute, Icahn School of Medicine at Mount Sinai
Randy A AlbrechtIcahn School of Medicine at Mount Sinai
Randy A AlbrechtGlobal Health and Emerging Pathogens Institute, Icahn School of Medicine at Mount Sinai
Eytan RuppinCenter for Cancer Research, National Cancer Institute, National Institute of Health
Jeffrey R JohnsonIcahn School of Medicine at Mount Sinai
Christopher BennerUniversity of California
Christopher BennerUniversity of California
Ren SunUniversity of California los angeles
Andrew I SuThe Scripps Research Institute
Andrew I SuThe Scripps Research Institute
Adolfo Garc??a-SastreIcahn School of Medicine at Mount Sinai
Adolfo Garc??a-SastreGlobal Health and Emerging Pathogens Institute, Icahn School of Medicine at Mount Sinai
Adolfo Garc??a-SastreIcahn School of Medicine at Mount Sinai
Adolfo Garc??a-SastreThe Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai
Sumit K ChandaSanford Burnham Prebys Medical Discovery Institute
  • 1 - 33

Datasets